123 related articles for article (PubMed ID: 3344727)
21. [Changes in arterial blood ammonia levels in cirrhosis. Study during and after mannitol lavage in post-hemorrhagic hepatic encephalopathy].
Doffoel M; Kopferschmitt J; Coumaros D; Girard M; Bockel R
Nouv Presse Med; 1978 Sep; 7(29):2575. PubMed ID: 309107
[No Abstract] [Full Text] [Related]
22. The effects of propranolol on hepatic encephalopathy in patients with cirrhosis and portal hypertension.
Dunk AA; Moore J; Symon A; Dickie A; Sinclair TS; Mowat NA; Brunt PW
Aliment Pharmacol Ther; 1988 Apr; 2(2):143-51. PubMed ID: 2979240
[TBL] [Abstract][Full Text] [Related]
23. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
24. Correlations between zinc, amino acids and ammonia in liver cirrhosis.
Grüngreiff K; Presser HJ; Franke D; Lössner B; Abicht K; Kleine FD
Z Gastroenterol; 1989 Dec; 27(12):731-5. PubMed ID: 2626852
[TBL] [Abstract][Full Text] [Related]
25. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
[TBL] [Abstract][Full Text] [Related]
26. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
[TBL] [Abstract][Full Text] [Related]
27. Capillary plasma ammonia concentration in neonates receiving total parenteral nutrition. Comparison with arterial and venous concentrations.
Schwartz JB; Cheng MH; Ramos AD; Merritt RJ; Platzker AC
J Perinatol; 1990 Dec; 10(4):376-9. PubMed ID: 2126032
[TBL] [Abstract][Full Text] [Related]
28. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
[TBL] [Abstract][Full Text] [Related]
29. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
30. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
Ferenci P; Wewalka F
Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
[TBL] [Abstract][Full Text] [Related]
31. [On enzymatic blood ammonia determination in liver patients with and without hepatic coma].
Müting D; Buhl H; Eschrich W; Reikowski H
Med Welt; 1966 Oct; 43():2288-93. PubMed ID: 5977110
[No Abstract] [Full Text] [Related]
32. [Propranolol in children and adolescents with portal hypertension: its dosage and the clinical, cardiovascular and biochemical effects].
de Kolster CC; Rapa de Higuera M; Carvajal A; Castro J; Callegari C; Kolster J
G E N; 1992; 46(3):199-207. PubMed ID: 1340825
[TBL] [Abstract][Full Text] [Related]
33. [The blood level of gamma-aminobutyric acid in patients with liver cirrhosis and portacaval anastomosis].
Kretz FJ; Löscher W; Dillinger U
Anaesthesiol Reanim; 1991; 16(3):169-74. PubMed ID: 1888423
[TBL] [Abstract][Full Text] [Related]
34. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy.
Douglass A; Al Mardini H; Record C
J Hepatol; 2001 May; 34(5):658-64. PubMed ID: 11434611
[TBL] [Abstract][Full Text] [Related]
35. [Glutamic acid gamma-ethyl ester in high doses in the treatment of high blood ammonia levels in severe hepatic failure].
Santagati G; Zibetti G; Grignani A
Minerva Med; 1978 Apr; 69(20):1367-74. PubMed ID: 566393
[TBL] [Abstract][Full Text] [Related]
36. [New aspects of the pathogenesis and therapy of alcoholic delirium (author's transl)].
Müting D; Reikowski J
MMW Munch Med Wochenschr; 1977 Feb; 119(7):209-12. PubMed ID: 403444
[TBL] [Abstract][Full Text] [Related]
37. [Hyperoctanoatemia and the hepatic encephalopathy of cirrhosis. 150 dosages in 61 patients (author's transl)].
Staeffen J; Rabinowitz JL; Aumonier P; Ballan P; Ferrer J; Terme R; Seriès C; Myerson RM
Nouv Presse Med; 1979 May; 8(20):1663-6. PubMed ID: 112576
[TBL] [Abstract][Full Text] [Related]
38. Propranolol does not alter cerebral blood flow and functions in cirrhotic patients without previous hepatic encephalopathy.
Calès P; Pierre-Nicolas M; Guell A; Mauroux JL; Franco-Sempe A; Vinel JP; Geraud G; Pascal JP
Hepatology; 1989 Mar; 9(3):439-42. PubMed ID: 2920999
[TBL] [Abstract][Full Text] [Related]
39. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension.
Reding P
Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697
[No Abstract] [Full Text] [Related]
40. Correlation between ammonia levels and the severity of hepatic encephalopathy.
Ong JP; Aggarwal A; Krieger D; Easley KA; Karafa MT; Van Lente F; Arroliga AC; Mullen KD
Am J Med; 2003 Feb; 114(3):188-93. PubMed ID: 12637132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
